CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in GLSI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$401,119

+$2,315 QoQ

Shares Held

17,098

+3.0% QoQ

Ownership

0.116%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 57 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. GLSI ranks #268 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$401,119	17,098	+3.0%	Shares	Sole	2026-08-14
2026-03-31	$398,804	16,603	-12.8%	Shares	Sole	2026-05-15
2025-12-31	$400,051	19,041	+0.2%	Shares	Sole	2026-02-13
2025-09-30	$189,069	19,002	-0.2%	Shares	Sole	2025-11-10
2025-06-30	$172,774	19,049	+0.2%	Shares	Sole	2025-08-12
2025-03-31	$181,326	19,007	+15.5%	Shares	Sole	2025-09-15
2024-12-31	$184,789	16,455	0.0%	Shares	Sole	2025-02-06
2024-09-30	$236,458	16,455	-10.8%	Shares	Sole	2024-11-12
2024-06-30	$318,516	18,454	+81.1%	Shares	Sole	2024-08-12
2022-03-31	$199,947	10,191	+3.8%	Shares	Sole	2022-05-13
2021-12-31	$238,896	9,819	0.0%	Shares	Sole	2022-02-11
2021-09-30	$383,628	9,819	0.0%	Shares	Sole	2021-11-16
2021-06-30	$441,265	9,819	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.